Cargando…
Comparison of Clinical Effects between Percutaneous Transluminal Septal Myocardial Ablation and Modified Morrow Septal Myectomy on Patients with Hypertrophic Cardiomyopathy
BACKGROUND: Percutaneous transluminal septal myocardial ablation (PTSMA) and modified Morrow septal myectomy (MMSM) are two invasive strategies used to relieve obstruction in patients with hypertrophic cardiomyopathy (HCM). This study aimed to determine the clinical outcome of these two strategies....
Autores principales: | Guo, Hong-Chang, Li, Jin-Hua, Jiang, Teng-Yong, Ren, Chang-Wei, Dai, Jiang, Zhou, Yu-Jie, Lai, Yong-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850667/ https://www.ncbi.nlm.nih.gov/pubmed/29483385 http://dx.doi.org/10.4103/0366-6999.226075 |
Ejemplares similares
-
Comparison of Modified With Classic Morrow Septal Myectomy in Treating Hypertrophic Obstructive Cardiomyopathy
por: Song, Bangrong, et al.
Publicado: (2016) -
Comparison of surgical results in patients with hypertrophic obstructive cardiomyopathy after classic or modified morrow septal myectomy
por: Lai, Yongqiang, et al.
Publicado: (2017) -
Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
por: Yang, Qiulan, et al.
Publicado: (2021) -
Percutaneous Transluminal Septal Myocardial Ablation for Hypertrophic Obstructive Cardiomyopathy Under Extracorporeal Membrane Oxygenation Support
por: Kobayashi, Takahiro, et al.
Publicado: (2020) -
Tips for Successful Septal Myectomy in Patients with Hypertrophic Cardiomyopathy
por: Kim, Jae Hyun
Publicado: (2018)